These interesting data gave reason to hypothesize that downregulation of TSPO in the brain could be a risk factor for the etiology of neuroinflammatory cognitive impairment, and increased TSPO might be a novel pharmacological treatment strategy for cognitive impairment. This evidence concerns the gene TSPO and Cognitive impairment.